Literature DB >> 17990086

Automated covariate selection and Bayesian model averaging in population PK/PD models.

David J Lunn1.   

Abstract

We illustrate the use of 'reversible jump' MCMC to automate the process of covariate selection in population PK/PD analyses. The output from such an approach can be used not only to determine the 'best' covariate model for each parameter, but also to formally measure the spread of uncertainty across all possible models, and to average inferences across a range of 'good' models. We examine the substantive impact of such model averaging compared to conditioning inferences on the 'best' model alone, and conclude that clinically significant differences between the two approaches can arise. The illustrative data that we consider pertain to the drug vancomycin in 59 neonates and infants, and all analyses are conducted using the WinBUGS software with newly developed 'Jump' interface installed.

Entities:  

Mesh:

Year:  2007        PMID: 17990086     DOI: 10.1007/s10928-007-9077-x

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  5 in total

1.  Bayesian analysis of population PK/PD models: general concepts and software.

Authors:  David J Lunn; Nicky Best; Andrew Thomas; Jon Wakefield; David Spiegelhalter
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-06       Impact factor: 2.745

2.  Estimation of population pharmacokinetic parameters of saquinavir in HIV patients with the MONOLIX software.

Authors:  Marc Lavielle; France Mentré
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-01-09       Impact factor: 2.745

3.  Pharmacokinetics and dose requirements of vancomycin in neonates.

Authors:  C Grimsley; A H Thomson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-11       Impact factor: 5.747

4.  A Bayesian toolkit for genetic association studies.

Authors:  David J Lunn; John C Whittaker; Nicky Best
Journal:  Genet Epidemiol       Date:  2006-04       Impact factor: 2.135

5.  Reversible jump Markov chain Monte Carlo for deconvolution.

Authors:  Dongwoo Kang; Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-01-13       Impact factor: 2.410

  5 in total
  5 in total

1.  Scaling of pharmacokinetics across paediatric populations: the lack of interpolative power of allometric models.

Authors:  Massimo Cella; Catherijne Knibbe; Saskia N de Wildt; Joop Van Gerven; Meindert Danhof; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335

Review 2.  Covariate selection in pharmacometric analyses: a review of methods.

Authors:  Matthew M Hutmacher; Kenneth G Kowalski
Journal:  Br J Clin Pharmacol       Date:  2015-01       Impact factor: 4.335

3.  Influence of covariate distribution on the predictive performance of pharmacokinetic models in paediatric research.

Authors:  Chiara Piana; Meindert Danhof; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2014-07       Impact factor: 4.335

4.  Paediatric drug development: are population models predictive of pharmacokinetics across paediatric populations?

Authors:  Massimo Cella; Wei Zhao; Evelyne Jacqz-Aigrain; David Burger; Meindert Danhof; Oscar Della Pasqua
Journal:  Br J Clin Pharmacol       Date:  2011-09       Impact factor: 4.335

5.  The impact of composite AUC estimates on the prediction of systemic exposure in toxicology experiments.

Authors:  Tarjinder Sahota; Meindert Danhof; Oscar Della Pasqua
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-04-14       Impact factor: 2.745

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.